Fact CheckerSign in

NCT06337552Active, not recruiting

High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

A Randomized High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial)

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

The purpose of the study is to evaluate the feasibility and acceptability of a dietary intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal cancer patients and non-small cell lung cancer (NSCLC) patients, and to explore whether this diet can improve outcomes in rectal cancer patients receiving chemoradiation and NSCLC patients receiving immunotherapy.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
39 (actual)
First submitted
18 Mar 2024
Start date
Apr 2024
Primary completion date
Jul 2026
Lead sponsor
H. Lee Moffitt Cancer Center and Research Institute
NCT number
NCT06337552

What you commit to

  • Study type: Interventional
  • Participants enrolled: 39
  • From Apr 2024 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Antibiotic use within 1 month prior to baseline
  • If currently using probiotics, unwillingness to cease probiotic use
  • Previous receipt of surgery, immunotherapy, chemotherapy, or radiation for a colon or rectal tumor
  • Infectious disease diagnosed \<1 month prior to baseline
  • Previously diagnosed with a mast cell disorder or histamine allergy

Other illness

  • Per clinician's discretion, clinician confirmed inflammatory bowel conditions (e.g., ulcerative colitis, Crohn's disease)

Other

  • Already consuming ≥2 servings of fermented foods/day

Who the study is looking for

  • 18 years of age or older
  • Diagnosed with locally advanced rectal cancer (Stage II-III)
  • Will undergo neoadjuvant chemoradiation at Moffitt Cancer Center
  • Able to pick up FFs once/weekly at Moffitt
  • Able to speak and read English
  • Able to consume foods orally
  • Able to provide informed consent
  • 18 years of age or older
  • Diagnosed with stage II-IV non-small cell lung cancer (NSCLC)
  • Will undergo Immunotherapy with immune checkpoint inhibitors (+/- chemotherapy or other treatment) at Moffitt Cancer Center
  • Able to pick up FFs once/weekly at Moffitt
  • Able to speak and read English
  • Able to consume foods orally
  • Able to provide informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Moffitt Cancer Center
Coordinator of this site? Confirm its status
TampaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.